Next Article in Journal
Basal Level p53 Suppresses Antiviral Immunity Against Foot-And-Mouth Disease Virus
Previous Article in Journal
Forced Degradation Studies to Identify Critical Process Parameters for the Purification of Infectious Measles Virus
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 11
Issue 8
10.3390/v11080726
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genetic Diversity of Sapoviruses among Inpatients in Germany, 2008−2018

by
Pia Mann
†,
Corinna Pietsch
*,† and
Uwe G. Liebert
Institute of Virology, Leipzig University, 04103 Leipzig, Germany
*
Author to whom correspondence should be addressed.
†
Those authors contributed equally to the work.
Viruses 2019, 11(8), 726; https://doi.org/10.3390/v11080726
Submission received: 4 July 2019 / Revised: 28 July 2019 / Accepted: 7 August 2019 / Published: 7 August 2019
(This article belongs to the Section Animal Viruses)
Browse Figures
Versions Notes

Abstract

:
Sapovirus enteric disease affects people of all ages across the globe, in both sporadic cases and outbreak settings. Sapovirus is seldom assessed in Germany and its epidemiology in the country is essentially unknown. Thus, sapovirus occurrence and genetic diversity were studied by real-time reverse transcription polymerase chain reaction (RT-PCR) and partial sequencing of major viral structural protein (VP1) gene in two different sets of stool samples: (1) a selection of 342 diarrheal stools collected from inpatient children during 2008−2009, and (2) 5555 stool samples collected during 2010–2018 from inpatients of all age groups with gastrointestinal complaints. Results showed year-round circulation of sapoviruses, with peaks during cooler months. In total, 30 samples (8.8%) of the first and 112 samples of the second set of samples (2.0%) were sapovirus positive. Capsid gene sequencing was successful in 134/142 samples (94.4%) and showed circulation of all known human pathogenic genogroups. Genotype GI.1 predominated (31.8%), followed by GII.1 (16.7%), GII.3 (14.5%), GI.2 (13.8%) and GV.1 (12.3%). Additionally, minor circulation of GI.3, GI.6, GII.2, GII.4, GII.6 and GIV.1 was shown. Consequently, sapovirus diagnostics need broadly reactive RT-PCR protocols and should particularly be considered in infants and young children. Further studies from other sampling sites are essential to extend our knowledge on sapovirus epidemiology in Germany.

1. Introduction

Throughout the world and among all age groups, human sapovirus infections are associated with acute gastroenteritis, in both sporadic cases and outbreak settings [1,2]. Among patients with sporadic gastroenteritis, sapoviruses were shown to rank second to fourth as the major viral pathogens [2]. In the post-rotavirus vaccine era, their role further increased [3]. Though tending to be somewhat milder, the clinical symptoms of sapovirus gastroenteritis are indistinguishable from those caused by noroviruses [4].
Sapoviruses were first described in 1976 [5] and their name refers to an outbreak in an orphanage in the city of Sapporo in Japan [6]. Along with noroviruses, sapoviruses are classified in the Caliciviridae family [7]. The human sapovirus genome is a 7.4–7.5 kb single-stranded, positive-sense RNA molecule with a 3’-end poly(A) tail. The genome commonly encodes two open reading frames (ORFs). Whereas ORF1 translation produces seven non-structural proteins (NS1−NS7) and the major capsid protein VP1, ORF2 is predicted to yield the minor capsid protein VP2 [8].
Based on the VP1 encoding nucleotide sequences, sapoviruses are classified into at least 15 genogroups (GI−GXV) [9], four of which (GI, GII, GIV and GV) are known to infect humans [2]. The human pathogenic sapoviruses in genogroups GI, GII and GV are currently subdivided into seven, eight and two genotypes, respectively (GI.1 to GI.7, GII.1 to GII.8, GV.1 and GV.2) [2,10]. In contrast, the GIV genogroup is less diverse and is thus placed into a single genotype [2].
There have been some long-term studies on the genetic diversity of sporadic human sapoviruses infections. Comprehensive data is available from Japan [11,12]. Recently, studies from Finland [3], South Africa [13], Peru [14] and India [15] substantially increased our knowledge on the global sapovirus genotype distribution.
Sapovirus infections have been reported in stool samples from outbreaks [16] and sporadic cases [17] of gastroenteritis from Germany. Yet unlike norovirus, sapovirus is rarely assessed in diarrhea outbreaks and sporadic sapovirus infections are not notifiable at the national level. Consequently, little is known about sapovirus epidemiology in the country. Thus, the present study aimed to investigate sapovirus occurrence and genetic diversity among inpatients from Germany.

2. Materials and Methods

2.1. Sample Collection

The presence of sapovirus RNA was assessed in two different sets of stool samples, which had been collected at Leipzig University Hospital, Germany. (1) Retrospective testing was done in 342 stool samples obtained in 2008–2009 from inpatient children with acute diarrhea, who aged less than five years. All the retrospective samples had previously shown negative results for noroviruses, rotaviruses, adenoviruses, astroviruses, enteroviruses and common enteropathogenic bacteria (Shigella spp., Salmonella spp., Yersinia enterocolitica and Campylobacter jejuni). (2) During nine consecutive years, 2010–2018, prospective testing was done in stool samples that had been sent to the laboratory for sapovirus routine diagnostics. In total, prospective testing included 5555 inpatients with acute or chronic diarrhea, abdominal pain or any other gastrointestinal complaints. Thereof, 1882 patients aged less than five years and 3673 patients were older. No information upon co-infections was yielded in this set of samples. The male to female ratio was 1:1.3 in both set of samples.

2.2. Analysis of Local Temperature

Local temperature datasets were provided by the Leipzig Institute for Meteorology, Faculty of Physics and Earth Sciences, Leipzig University, and were compiled to calculate mean monthly temperatures.

2.3. Nucleic Acid Extraction and Sapovirus RNA Detection

Ten-percent stool sample suspensions were prepared in phosphate buffered saline and clarified by centrifugation at 3000 g for ten minutes. Total RNA was extracted (MagNA Pure system, Roche Applied Science, Mannheim, Germany) and RNA aliquots were stored at −80 °C. Presence of human pathogenic GI, GII, GIV and GV sapovirus RNA was assessed by a real-time RT-PCR that target the polymerase–capsid junction region of the viral genome [18]. Briefly, amplicons were generated as recommended by the manufacturer (QuantiFast Probe PCR Kit, OneStep, Qiagen, Hilden, Germany) and detected in real-time by a fluorescent locked nucleic acid probe (5’-FAM-TGGTWYATW+G+G+T+GG-BBQ-3’; TIB Molbiol GmbH, Berlin, Germany) in air-heated glass capillaries (LightCycler 2.0, Roche, Mannheim, Germany). To exclude failure in amplicon detection by probe mismatches, all obtained RT-PCR reaction products were subsequently evaluated by agarose gel electrophoresis.

2.4. Nucleic Acid Sequencing

To confirm sapovirus positivity, RT-PCR amplicons of specific size were gel purified (Wizard SV Gel and PCR Clean-Up System, Promega, Mannheim, Germany) and sequenced (BigDye Terminator v1.1 Cycle Sequencing kit and ABI 3500 Genetic Analyzer, PE Applied Biosystems, Foster City, CA, USA) using the consensus reverse primer SaV1245R [18]. In all confirmed sapovirus positive samples, partial ORF1 (806–826 bp) was amplified by real-time PCR forward primers and genotype-specific reverse primers (Table 1) following the manufacturer’s instructions (OneStep RT-PCR Kit, Qiagen, Hilden, Germany).
To enhance genotyping sensitivity, a second-round PCR was performed in samples with low viral load. Forward primer 1245Rfwd (5’-TAGTGTTTGARATGGAGGG-3’) [19] and the genotype-specific reverse primer (Table 1) were used to amplify 710−739 bp of the VP1 gene. If amplification of partial VP1 by genotype-specific reverse primers failed, genogroup-specific reverse primers (SaV-VP1-GI.x-R and SaV-VP1-GII.x-R) were used in a semi-nested RT-PCR in their place.
Amplicons of partial VP1 were gel purified and sequenced (see above) using the applied (semi-nested) PCR forward and reverse primers. Sequence electropherograms were aligned, analyzed and corrected (Geneious v10, Biomatters Ltd., Auckland, New Zealand). The obtained partial VP1 sequences have been deposited in the GenBank database (GenBank accession no. MN164878 to MN165004). More comprehensive nucleotide sequences of seven of the detected sapovirus strains have been published previously (GenBank accession no., MH541021, MH541030, MH541033, MH541039, MH541043, MH763826 and MH763827) [20].

2.5. Phylogenetic Analysis and VP1 Genotyping

Partial VP1 nucleic acid sequence alignments (667−697 bp) of the present sapovirus strains and available reference data from GenBank of sufficient length were phylogenetically analyzed using the Maximum Likelihood algorithm in MEGA5 [21]. Statistical support was assessed by bootstrapping with 1000 replicates. Based on the phylogenetic clustering of strains, genotypes were assigned following the proposed genotype nomenclature [2].

2.6. Nosocomial Sapovirus Infections

To evaluate the impact of nosocomial outbreaks on the results of genotype distribution and phylogeny of circulating strains, sapovirus infections were classified as community-acquired and nosocomial based on patients’ records review. Infections were classified as nosocomial if the symptoms first appeared 48 or more hours after hospital admission.

2.7. Ethical Considerations

This non-interventional study included no additional procedures. Anonymized biological material was obtained only for standard viral diagnosis. Informed consent for storage and further use of samples was obtained from all patients. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Leipzig University (26 September 2016, AZ 298/16-ek).

3. Results

3.1. Sapovirus Stool Positivity

Sapovirus RNA was shown in 142 of 5897 stool samples (2.4%). There was no significant difference in sapovirus stool positivity rate between male (2.4%) and female (2.5%) patients. The stool positivity rate was higher in retrospective testing of preselected samples than in prospective testing of unselected samples (Table 2). Samples from children aged six months to two years showed the highest positivity rates in both sets of samples. Lower positivity rates were shown in patients beyond the fourth year of life and in the subset of young infants of less than six months of age in the prospective cohort.
Sapoviruses were detected throughout the year (Figure 1). In the prospective subset of children within the first four years of life, highest positivity rates were shown from November to March (5.5−9.2%). Samples collected during the cool late fall to spring months were three to four times more likely to be sapovirus positive than those obtained during warmer summer and early fall (odds ratio = 3.67; 95% CI = 1.83−7.37). Sapovirus positivity rates also varied between the different sampling years and ranged from 0.5−2.9% through the years 2010−2018 (Figure 2).

3.2. Sapovirus Genotypes

Amplification and nucleic acid sequencing of the partial VP1 gene was successful in 134/142 samples (94.4%). Sapoviruses of all known human pathogenic genogroups were detected (Figure 2). In genotype distribution, GI.1 (30.3%) strains prevailed and were followed by GII.1 (15.5%), GII.3 (14.1%), GI.2 (12.7%) and GV.1 (11.3%) sapoviruses. Minor circulation was shown for GII.2 (4.9%), GII.5 (2.1%), GI.6 (1.4%), GI.3, GII.4 and GIV.1 (0.7% each) genotypes.
Sapovirus genotype distribution fluctuated during the study period (Figure 2). The detected diversity was highest in 2018, when at least ten different sapovirus genotypes were shown in the obtained stool samples. The overall prevailing GI.1 sapoviruses circulated in all years but 2008. In contrast, rare GI.3, GI.6, GII.4, GII.5 and GIV.1 strains were only detected in a single year each.

3.3. Sapovirus Phylogenetic Analysis

Within the sapovirus genotypes, variants from different intragenotypic lineages co-circulated (Figure 3). The partial VP1 gene nucleotide identity between the present GI.1 sapoviruses ranged from 94.4% to 100%. Viruses of the GI.1b lineage (n = 32) predominated over GI.1a strains (n = 11) (Figure 3a). Both intragenotypic lineages were detected in several sampling years. The present GI.1b sequences clustered with reference strains from multiple continents, including sapoviruses from Ireland, the USA, Ethiopia, Korea, Japan and Peru. A similar geographic distribution was shown for related GI.1a reference strains originating from Russia, the USA, China and Japan. For the present GI.1b strain Hu/DE/2018/GI.1/Leipzig128 recent travel history of the patient to Pakistan was recorded. The patient had returned from travel three days before hospital admission.
The nucleotide identity of the present GI.2 strains was high (98.0−100%). They were detected in eight of the eleven sampling years (Figure 2) and all belonged to one big phylogenetic cluster (Figure 3b). The majority of the recent reference sequences were part of the same phylogenetic cluster, too. A GI.3 strain was detected in 2012 and clustered in the intragenotypic lineage GI.3b. It was related to strains from Brazil and Japan, which had been collected during 2009−2015. Identical partial GI.6 VP1 sequences were obtained from two samples collected in 2018 from patients with nosocomial sapovirus infections. They belonged to the intragenotypic lineage GI.6b and clustered with a recent strain reported from the USA in 2015.
In genogroup GII sapoviruses, five different genotypes were detected (Figure 2). The nucleotide identity of partial GII.1 VP1 genes was 91.1−100% and the present strains belonged to two different intragenotypic lineages (Figure 3c). Whereas samples from 2008 to 2018 clustered in lineage GII.1a together with strains from Ireland, Russia and France, lineage GII.1b sequences were only detected since 2015 and showed relatedness to strains from Ethiopia, the USA and Japan. Seven GII.2 strains were detected in the years 2010−2018. Their nucleotide identity was high (94.9−99.9%) and they all clustered in lineage GII.2a with strains from Ethiopia, Thailand, Japan, Taiwan and the USA. For GII.3 sapoviruses, nucleotide identity was lower (85.9%−100%). Whereas all strains from 2008 to 2010 were part of the intragenotypic lineage GII.3a, more recently, GII.3b strains were exclusively detected. The GII.3a strains clustered with reference strains from Japan and China. For GII.3b strains related strains from China, Japan, Taiwan and Russia were available in the GenBank. The present GII.4 sapovirus from 2018 clustered with reference strains from Ireland, the Philippines, Ethiopia and Peru in intragenotypic lineage GII.4b. For GII.5, two different VP1 sequences were shown. One of which was detected in a patient in 2010, the other in two nosocomially infected patients in 2018. Their nucleotide identity was 94.5%. Phylogenetic comparison with the limited number of available reference sequences showed relatedness to strains from the USA and Guatemala.
The genotype GIV.1 sapovirus was shown in one of the present patients. Its sequence from 2018 clustered with strains from the USA (nucleotide identities 98.7−98.8%) and Peru (nucleotide identity 99.1%), collected in 2014 and 2015, respectively (Figure 3d). All the present sixteen GV.1 sequences were highly homologous (97.3−100%), as were the majority of the available global reference sequences (Figure 3d).

3.4. Nosocomial Sapovirus Infections

Nosocomial infections occurred in 31/142 sapovirus positive patients (21.8%; 95% CI = 15.8−29.3%). The sapovirus partial VP1 sequences from nosocomial infections clustered in different genotypes, intragenotypic lineages and sub-clusters (Figure 3). In none of the phylogenetic sub-clusters more than two nosocomial cases grouped.

4. Discussion

This is the first report to provide comprehensive data on molecular epidemiology of human sapoviruses circulating at a sampling site in Germany. The applied partial VP1 genotyping approach was successful in the vast majority of detected sapoviruses and proved circulation of all known human pathogenic genogroups in the local human population. The genetic diversity of the detected human sapoviruses was high and minor genotypes were present.
In the past, sapovirus GI.1 [16,17,22], GI.2 (GenBank accessions AF294739 and JX993277), GII.1 [16], GII.5 [17] and GIV.1 (GenBank accession AY424804) strains were sporadically observed in isolated human stool samples from Germany. Unfortunately, those sapovirus detections typically provided exclusively short partial polymerase [16] or no sequence data at all [17]. In contrast, the present data is generated from stool samples collected during subsequent years in the same setting and area. Furthermore, sapovirus typing was based on partial VP1 amplification using sensitive genotype specific primers, supplemented with a second-round semi-nested PCR when necessary.
The final phylogenetic analysis was based on sequencing data spanning more than one third of the VP1 gene, which exceeds the coverage of common sapovirus genotyping approaches [3,11,13,14,15,23,24,25,26]. The more comprehensive sequencing data obtained thus allowed marking out intragenotypic lineages and clusters in phylogenetic trees comprising present strains and reference sequence data from GenBank. In this way, local circulation of sapoviruses from distinct intragenotypic lineages was shown for three of the detected genotypes (GI.1, GII.1 and GII.3). In contrast, all present GI.2 strains belonged to a single phylogenetic cluster, which is in agreement with the previously reasoned rapid spread of a novel GI.2 drift variant since 2007 and its subsequent persistence in the human population [27,28].
Consistent with previous studies [3,11,13,14,15,25], sapovirus genotype distribution fluctuated between sampling years. In the whole, GI.1, GII.1 and GI.2 predominated, which have commonly been among the major genotypes in other European countries [3,23,24,25,26,28,29] and beyond [11,14,30,31]. Notably, occasional nosocomial sapovirus infections by various sapoviruses but no major outbreaks were identified in the present patients. Thus, no substantial bias by nosocomial spread towards a specific genotype is assumed for the established genotype distribution.
Phylogenetic relatedness to sapoviruses from several countries and continents was shown for the majority of the present strains. This finding points to a global circulation of sapoviruses and common introductions of new strains into the local population. Obvious vehicles for global virus spread are returning travelers [32]. Such an event may as well explain the unique GI.1 strain in one stool sample detected subsequent to the patient’s visit to Pakistan.
Confirming findings of previous studies conducted in the temperate climate zone [3,23,33,34], sapovirus year-round circulation with peak positivity in late autumn to early spring months was shown. The established stool positivity rates in the range of 0.5−12.8%, depending on preselection of samples and patients’ age, are in line with results from inpatient samples in previous European studies. For instance, sapovirus positivity was 2.4−10.9% in diarrheic feces collected from young inpatients in Italy [24,35] and 6% in inpatient children from the UK [34]. In contrast, recent data from Spain and Denmark point to a possibly higher sapovirus stool positivity rate (15.6−21.6%) among pediatric outpatients and child care center attendees with clinical symptoms of acute gastroenteritis [23,36].
Unfortunately, stool samples of asymptomatic community controls could not be obtained during the study. Thus, based on the data gathered, association of sapovirus presence with clinical symptoms of acute gastroenteritis [36,37,38] could not be thoroughly assessed. Nevertheless, age-stratified sapovirus stool positivity rates were higher in the present retrospective than in the prospective set of samples, whatever the year. Besides sampling years, the inclusion criteria regarding patients’ clinical symptoms represent the major difference between both sets of samples. Whereas the retrospective samples consisted exclusively of feces from children with clinical signs of acute gastroenteritis, the prospective set additionally included samples from patients with chronic diarrhea [20], abdominal pain or any other gastrointestinal complaints.
On the subject of age distribution, the present data shows sapovirus peak positivity during 0.5−2 years of age. Consistently, sapovirus positivity in Danish patients with sporadic gastroenteritis was 3% in the age group of 0−6 months but 12% in older infants and children [25]. The finding of low sapovirus stool positivity during the early months of life was confirmed by other studies [14,15] and suggests a possible protective effect of maternal transplacental and milk antibodies [39,40]. In line with data from Spain and Japan, sapovirus positivity declined again beyond preschool age [23,41]. This observation may be conceivably explained by adaptive sapovirus-specific humoral immunity established during serial sapovirus infection in early childhood [40,42,43,44].
The present study captures sapovirus epidemiology at a single sampling site and is therefore not designed to provide conclusions on the situation all over Germany. It is a well-known fact that occurrence and genetic diversity of sapoviruses may considerably differ between sampling sites [13,30]. Obviously, results are also heavily influenced by the sensitivity and specificity of the applied detection protocols. Though real-time RT-PCR is the gold standard for sapovirus detection [2], its sensitivity is a true challenge in the light of the vast genetic diversity of this viral genus. Continued discoveries of further human pathogenic genotypes [10,45] demand critical review and updates of oligonucleotides for many established sapovirus detection protocols [2,46]. This applies as well to the present one, as comprehensive in silico analysis of currently available sapovirus sequencing data revealed probable detection failure for some human pathogenic genotypes discovered in the meantime, like GII.8 and GV.2 (own unpublished observation). Hence it follows that the established sapovirus positivity rates of the present study have to be considered underestimated. Similarly, the local genetic diversity is presumably higher, even more so as accompanying polymerase sequences would be necessary to assess circulation of sapovirus recombinant strains [47,48].
In conclusion, sapovirus diagnostics should particularly be considered in stool samples from infants and young children with acute gastroenteritis. The genetic diversity of circulating strains is extensive and their genotype distribution varies. Since global spread of emerging sapovirus variants may be fast, novel strains can be rapidly introduced into local settings. Consequently, broadly reactive real-time RT-PCRs should preferably be implemented. Noteworthy, protocols and oligonucleotides may need updates on a regular basis to ensure sustained high sensitivities of the assay. Further studies on more extensive sample sets and from multiple sampling sites are needed and should preferably include outpatients as well as asymptomatic controls to extend our knowledge on sapovirus epidemiology in Germany.

Author Contributions

Conceptualization, C.P. and U.G.L.; methodology, P.M. and C.P.; validation, P.M. and C.P.; writing—original draft preparation, P.M. and C.P.; writing—review and editing, U.G.L.; visualization, P.M. and C.P.; supervision, U.G.L.

Funding

This research was partially supported by Vereinigung von Förderern und Freunden der Universität Leipzig (Association of Sponsors and Friends of Leipzig University). We further acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.

Acknowledgments

Our special thanks go to Sandra Bergs for her excellent technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Thongprachum, A.; Khamrin, P.; Maneekarn, N.; Hayakawa, S.; Ushijima, H. Epidemiology of gastroenteritis viruses in Japan: Prevalence, seasonality, and outbreak. J. Med. Virol. 2016, 88, 551–570. [Google Scholar] [CrossRef] [PubMed]
  2. Oka, T.; Wang, Q.; Katayama, K.; Saif, L.J. Comprehensive review of human sapoviruses. Clin. Microbiol. Rev. 2015, 28, 32–53. [Google Scholar] [CrossRef] [PubMed]
  3. Pitkanen, O.; Vesikari, T.; Hemming-Harlo, M. The role of the sapovirus infection increased in gastroenteritis after national immunisation was introduced. Acta Paediatr. 2019, 108, 1338–1344. [Google Scholar] [CrossRef] [PubMed]
  4. Sakai, Y.; Nakata, S.; Honma, S.; Tatsumi, M.; Numata-Kinoshita, K.; Chiba, S. Clinical severity of Norwalk virus and Sapporo virus gastroenteritis in children in Hokkaido, Japan. Pediatr. Infect. Dis. J. 2001, 20, 849–853. [Google Scholar] [CrossRef] [PubMed]
  5. Madeley, C.R.; Cosgrove, B.P. Letter: Caliciviruses in man. Lancet 1976, 1, 199–200. [Google Scholar] [CrossRef]
  6. Chiba, S.; Sakuma, Y.; Kogasaka, R.; Akihara, M.; Horino, K.; Nakao, T.; Fukui, S. An outbreak of gastroenteritis associated with calicivirus in an infant home. J. Med. Virol. 1979, 4, 249–254. [Google Scholar] [CrossRef] [PubMed]
  7. Desselberger, U. Caliciviridae Other Than Noroviruses. Viruses 2019, 11, 286. [Google Scholar] [CrossRef]
  8. Liu, B.L.; Clarke, I.N.; Caul, E.O.; Lambden, P.R. Human enteric caliciviruses have a unique genome structure and are distinct from the Norwalk-like viruses. Arch. Virol. 1995, 140, 1345–1356. [Google Scholar] [CrossRef]
  9. Oka, T.; Lu, Z.; Phan, T.; Delwart, E.L.; Saif, L.J.; Wang, Q. Genetic Characterization and Classification of Human and Animal Sapoviruses. PLoS ONE 2016, 11, e0156373. [Google Scholar] [CrossRef]
  10. Xue, L.; Cai, W.; Gao, J.; Jiang, Y.; Wu, H.; Zhang, L.; Zuo, Y.; Dong, R.; Pang, R.; Zeng, H.; et al. Genome characteristics and molecular evolution of the human sapovirus variant GII.8. Infect. Genet. Evol. 2019, 73, 362–367. [Google Scholar] [CrossRef]
  11. Yoneda, M.; Nakano, M.; Sugimoto, D.; Inada, M.; Fujitani, M.; Kitahori, Y. Epidemiological Characteristics of Sapovirus and Human Astrovirus Detected among Children in Nara Prefecture, Japan, during the 2009/2010–2014/2015 Seasons. Jpn. J. Infect. Dis. 2017, 70, 87–91. [Google Scholar] [CrossRef]
  12. Harada, S.; Tokuoka, E.; Kiyota, N.; Katayama, K.; Oka, T. Phylogenetic analysis of the nonstructural and structural protein encoding region sequences, indicating successive appearance of genomically diverse sapovirus strains from gastroenteritis patients. Jpn. J. Infect. Dis. 2013, 66, 454–457. [Google Scholar] [CrossRef]
  13. Murray, T.Y.; Nadan, S.; Page, N.A.; Taylor, M.B. Diverse sapovirus genotypes identified in children hospitalised with gastroenteritis in selected regions of South Africa. J. Clin. Virol. 2016, 76, 24–29. [Google Scholar] [CrossRef] [Green Version]
  14. Sanchez, G.J.; Mayta, H.; Pajuelo, M.J.; Neira, K.; Xiaofang, L.; Cabrera, L.; Ballard, S.B.; Crabtree, J.E.; Kelleher, D.; Cama, V.; et al. Epidemiology of Sapovirus Infections in a Birth Cohort in Peru. Clin. Infect. Dis. 2018, 66, 1858–1863. [Google Scholar] [CrossRef]
  15. Lasure, N.; Gopalkrishna, V. Epidemiological profile and genetic diversity of sapoviruses (SaVs) identified in children suffering from acute gastroenteritis in Pune, Maharashtra, Western India, 2007–2011. Epidemiol. Infect. 2017, 145, 106–114. [Google Scholar] [CrossRef]
  16. Ike, A.C.; Hartelt, K.; Oehme, R.M.; Brockmann, S.O. Detection and characterization of sapoviruses in outbreaks of gastroenteritis in southwest Germany. J. Clin. Virol. 2008, 43, 37–41. [Google Scholar] [CrossRef]
  17. Moser, O.; Luck, S.; Dilloo, D.; Eis-Hubinger, A.M.; Simon, A. Sapovirus as a gastrointestinal pathogen in febrile pediatric patients with cancer. J. Med. Virol. 2011, 83, 2233–2236. [Google Scholar] [CrossRef]
  18. Oka, T.; Katayama, K.; Hansman, G.S.; Kageyama, T.; Ogawa, S.; Wu, F.T.; White, P.A.; Takeda, N. Detection of human sapovirus by real-time reverse transcription-polymerase chain reaction. J. Med. Virol. 2006, 78, 1347–1353. [Google Scholar] [CrossRef]
  19. Kitajima, M.; Oka, T.; Haramoto, E.; Katayama, H.; Takeda, N.; Katayama, K.; Ohgaki, S. Detection and genetic analysis of human sapoviruses in river water in Japan. Appl. Environ. Microbiol. 2010, 76, 2461–2467. [Google Scholar] [CrossRef]
  20. Pietsch, C.; Liebert, U.G. Intrahost viral evolution during chronic sapovirus infections. J. Clin. Virol. 2019, 113, 1–7. [Google Scholar] [CrossRef]
  21. Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28, 2731–2739. [Google Scholar] [CrossRef] [PubMed]
  22. Fullerton, S.W.; Blaschke, M.; Coutard, B.; Gebhardt, J.; Gorbalenya, A.; Canard, B.; Tucker, P.A.; Rohayem, J. Structural and functional characterization of sapovirus RNA-dependent RNA polymerase. J. Virol. 2007, 81, 1858–1871. [Google Scholar] [CrossRef] [PubMed]
  23. Varela, M.F.; Rivadulla, E.; Lema, A.; Romalde, J.L. Human Sapovirus among Outpatients with Acute Gastroenteritis in Spain: A One-Year Study. Viruses 2019, 11, 144. [Google Scholar] [CrossRef]
  24. Medici, M.C.; Tummolo, F.; Albonetti, V.; Abelli, L.A.; Chezzi, C.; Calderaro, A. Molecular detection and epidemiology of astrovirus, bocavirus, and sapovirus in Italian children admitted to hospital with acute gastroenteritis, 2008–2009. J. Med. Virol. 2012, 84, 643–650. [Google Scholar] [CrossRef]
  25. Johnsen, C.K.; Midgley, S.; Bottiger, B. Genetic diversity of sapovirus infections in Danish children 2005-2007. J. Clin. Virol. 2009, 46, 265–269. [Google Scholar] [CrossRef]
  26. Gallimore, C.I.; Iturriza-Gomara, M.; Lewis, D.; Cubitt, D.; Cotterill, H.; Gray, J.J. Characterization of sapoviruses collected in the United Kingdom from 1989 to 2004. J. Med. Virol. 2006, 78, 673–682. [Google Scholar] [CrossRef]
  27. Iritani, N.; Yamamoto, S.P.; Abe, N.; Kubo, H.; Oka, T.; Kaida, A. Epidemics of GI.2 sapovirus in gastroenteritis outbreaks during 2012–2013 in Osaka City, Japan. J. Med. Virol. 2016, 88, 1187–1193. [Google Scholar] [CrossRef]
  28. Svraka, S.; Vennema, H.; van der Veer, B.; Hedlund, K.O.; Thorhagen, M.; Siebenga, J.; Duizer, E.; Koopmans, M. Epidemiology and genotype analysis of emerging sapovirus-associated infections across Europe. J. Clin. Microbiol. 2010, 48, 2191–2198. [Google Scholar] [CrossRef]
  29. Chhabra, P.; Samoilovich, E.; Yermalovich, M.; Chernyshova, L.; Gheorghita, S.; Cojocaru, R.; Shugayev, N.; Sahakyan, G.; Lashkarashvili, M.; Chubinidze, M.; et al. Viral gastroenteritis in rotavirus negative hospitalized children <5 years of age from the independent states of the former Soviet Union. Infect. Genet. Evol. 2014, 28, 283–288. [Google Scholar] [CrossRef]
  30. Gelaw, A.; Pietsch, C.; Mann, P.; Liebert, U.G. Molecular detection and characterisation of sapoviruses and noroviruses in outpatient children with diarrhoea in Northwest Ethiopia. Epidemiol. Infect. 2019, 147, e218. [Google Scholar] [CrossRef] [Green Version]
  31. Magwalivha, M.; Kabue, J.-P.; Traore, A.N.; Potgieter, N. Prevalence of Human Sapovirus in Low and Middle Income Countries. Adv. Virol. 2017, 2018, 5986549. [Google Scholar] [CrossRef]
  32. Pouletty, M.; de Pontual, L.; Lopez, M.; Morin, L.; Poilane, I.; Pham, L.L.; Carbonnelle, E.; Titomanlio, L.; Faye, A.; Bonacorsi, S. Multiplex PCR reveals a high prevalence of multiple pathogens in traveller’s diarrhoea in children. Arch. Dis. Child. 2018. [Google Scholar] [CrossRef]
  33. Nakamura, N.; Kobayashi, S.; Minagawa, H.; Matsushita, T.; Sugiura, W.; Iwatani, Y. Molecular epidemiology of enteric viruses in patients with acute gastroenteritis in Aichi prefecture, Japan, 2008/09–2013/14. J. Med. Virol. 2016, 88, 1180–1186. [Google Scholar] [CrossRef]
  34. Brown, J.R.; Shah, D.; Breuer, J. Viral gastrointestinal infections and norovirus genotypes in a paediatric UK hospital, 2014-2015. J. Clin. Virol. 2016, 84, 1–6. [Google Scholar] [CrossRef]
  35. Bergallo, M.; Galliano, I.; Montanari, P.; Brusin, M.R.; Finotti, S.; Paderi, G.; Gabiano, C. Development of a quantitative real-time PCR assay for sapovirus in children under 5-years-old in Regina Margherita Hospital of Turin, Italy. Can. J. Microbiol. 2017, 63, 296–302. [Google Scholar] [CrossRef]
  36. Hebbelstrup Jensen, B.; Jokelainen, P.; Nielsen, A.C.Y.; Franck, K.T.; Rejkjaer Holm, D.; Schonning, K.; Petersen, A.M.; Krogfelt, K.A. Children Attending Day Care Centers are a Year-round Reservoir of Gastrointestinal Viruses. Sci. Rep. 2019, 9, 3286. [Google Scholar] [CrossRef]
  37. Ouedraogo, N.; Kaplon, J.; Bonkoungou, I.J.; Traore, A.S.; Pothier, P.; Barro, N.; Ambert-Balay, K. Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso. PLoS ONE 2016, 11, e0153652. [Google Scholar] [CrossRef]
  38. Bucardo, F.; Carlsson, B.; Nordgren, J.; Larson, G.; Blandon, P.; Vilchez, S.; Svensson, L. Susceptibility of children to sapovirus infections, Nicaragua, 2005–2006. Emerg. Infect. Dis. 2012, 18, 1875–1878. [Google Scholar] [CrossRef]
  39. Yang, B.; Yang, B.; Shan, X.; Li, B.; Ma, X.; Yin, X.; Zhang, Y.; Liu, Y.; Lan, X. Short communication: Immune responses in sows induced by porcine sapovirus virus-like particles reduce viral shedding in suckled piglets. Res. Vet. Sci. 2017, 117, 196–199. [Google Scholar] [CrossRef]
  40. Farkas, T.; Deng, X.; Ruiz-Palacios, G.; Morrow, A.; Jiang, X. Development of an enzyme immunoassay for detection of sapovirus-specific antibodies and its application in a study of seroprevalence in children. J. Clin. Microbiol. 2006, 44, 3674–3679. [Google Scholar] [CrossRef]
  41. Thongprachum, A.; Takanashi, S.; Kalesaran, A.F.; Okitsu, S.; Mizuguchi, M.; Hayakawa, S.; Ushijima, H. Four-year study of viruses that cause diarrhea in Japanese pediatric outpatients. J. Med. Virol. 2015, 87, 1141–1148. [Google Scholar] [CrossRef]
  42. Nakata, S.; Chiba, S.; Terashima, H.; Yokoyama, T.; Nakao, T. Humoral immunity in infants with gastroenteritis caused by human calicivirus. J. Infect. Dis. 1985, 152, 274–279. [Google Scholar] [CrossRef]
  43. Lauritsen, K.T.; Hansen, M.S.; Johnsen, C.K.; Jungersen, G.; Bottiger, B. Repeated examination of natural sapovirus infections in pig litters raised under experimental conditions. Acta Vet. Scand. 2015, 57, 60. [Google Scholar] [CrossRef]
  44. Harada, S.; Oka, T.; Tokuoka, E.; Kiyota, N.; Nishimura, K.; Shimada, Y.; Ueno, T.; Ikezawa, S.; Wakita, T.; Wang, Q.; et al. A confirmation of sapovirus re-infection gastroenteritis cases with different genogroups and genetic shifts in the evolving sapovirus genotypes, 2002–2011. Arch. Virol. 2012, 157, 1999–2003. [Google Scholar] [CrossRef]
  45. Diez-Valcarce, M.; Montmayeur, A.; Tatusov, R.; Vinje, J. Near-Complete Human Sapovirus Genome Sequences from Kenya. Microbiol. Resour. Announc. 2019, 8. [Google Scholar] [CrossRef]
  46. Oka, T.; Iritani, N.; Yamamoto, S.P.; Mori, K.; Ogawa, T.; Tatsumi, C.; Shibata, S.; Harada, S.; Wu, F.T. Broadly reactive real-time reverse transcription-polymerase chain reaction assay for detection of human sapovirus genotypes. J. Med. Virol. 2018. [Google Scholar] [CrossRef]
  47. Chanit, W.; Thongprachum, A.; Khamrin, P.; Okitsu, S.; Mizuguchi, M.; Ushijima, H. Intergenogroup recombinant sapovirus in Japan, 2007–2008. Emerg. Infect. Dis. 2009, 15, 1084–1087. [Google Scholar] [CrossRef]
  48. Dey, S.K.; Mizuguchi, M.; Okitsu, S.; Ushijima, H. Novel recombinant sapovirus in Bangladesh. Clin. Lab. 2011, 57, 91–94. [Google Scholar]
Viruses 11 00726 g001 550
Figure 1. Average sapovirus stool positivity rate per month. Results from samples collected in 2010−2018 from diarrheic inpatients of less than five years of age (n = 1882) are shown by grey bars. The dashed black line indicates the local mean temperature per month during the sampling period. The sapovirus stool positivity rate in cold and warm months differed significantly (***, p ≤ 0.001).
Figure 1. Average sapovirus stool positivity rate per month. Results from samples collected in 2010−2018 from diarrheic inpatients of less than five years of age (n = 1882) are shown by grey bars. The dashed black line indicates the local mean temperature per month during the sampling period. The sapovirus stool positivity rate in cold and warm months differed significantly (***, p ≤ 0.001).
Viruses 11 00726 g001
Viruses 11 00726 g002 550
Figure 2. Yearly distribution of sapovirus genotypes detected in stool samples from inpatients in Germany. Additionally, the number of tested samples (n total), the number of sapovirus positive samples (n pos) and the sapovirus positivity rate (PR) for each sampling year are shown at the bottom. Total numbers per genotype are indicated at the very right. Of note, samples collected in 2008 and 2009 were preselected and restricted to feces from diarrheic under-5 children without enteric co-infections. In contrast, samples from 2010 to 2018 were not preselected and included feces of patients of all age groups.
Figure 2. Yearly distribution of sapovirus genotypes detected in stool samples from inpatients in Germany. Additionally, the number of tested samples (n total), the number of sapovirus positive samples (n pos) and the sapovirus positivity rate (PR) for each sampling year are shown at the bottom. Total numbers per genotype are indicated at the very right. Of note, samples collected in 2008 and 2009 were preselected and restricted to feces from diarrheic under-5 children without enteric co-infections. In contrast, samples from 2010 to 2018 were not preselected and included feces of patients of all age groups.
Viruses 11 00726 g002
Viruses 11 00726 g003a 550Viruses 11 00726 g003b 550Viruses 11 00726 g003c 550Viruses 11 00726 g003d 550
Figure 3. Phylogenetic analysis of partial VP1 sequences (667−697 bp) at the nucleotide level. Separate trees are shown for (a) GI.1, (b) GI.2, GI.3, GI.4 and GI.6, (c) genogroup GII, and (d) genogroup GIV and GV sapoviruses. The trees were constructed using the Maximum Likelihood method implemented in MEGA5 software. Bootstraps values (1000 replicates) above 80% are shown. Sapovirus genotypes and intragenotypic lineages are indicated at the right. Strains of the present study are pointed out by black circles. Those detected in nosocomial sapovirus infections are additionally labelled with black triangles.
Figure 3. Phylogenetic analysis of partial VP1 sequences (667−697 bp) at the nucleotide level. Separate trees are shown for (a) GI.1, (b) GI.2, GI.3, GI.4 and GI.6, (c) genogroup GII, and (d) genogroup GIV and GV sapoviruses. The trees were constructed using the Maximum Likelihood method implemented in MEGA5 software. Bootstraps values (1000 replicates) above 80% are shown. Sapovirus genotypes and intragenotypic lineages are indicated at the right. Strains of the present study are pointed out by black circles. Those detected in nosocomial sapovirus infections are additionally labelled with black triangles.
Viruses 11 00726 g003aViruses 11 00726 g003bViruses 11 00726 g003cViruses 11 00726 g003d
Table
Table 1. Reverse primers used in sapovirus VP1 genotyping.
Table 1. Reverse primers used in sapovirus VP1 genotyping.
GenotypeReverse PrimerSequence (5’→3’)
GI.1SaV-VP1-GI.1-RTCTGGTGARACYCCRTTYTCCAT
GI.2SaV-VP1-GI.2-RTCAGGTGACACACCATTBTCCAT
GI.3SaV-VP1-GI.3-RTCAGGTGACAMYCCRTTYTCCAT
GI.6SaV-VP1-GI.6-RTCAGGGGACACACCRTTYTCCAT
GI.xSaV-VP1-GI.x-RTCRGGKGAVAHNCCRTTBTSCAT
GII.1SaV-VP1-GII.1-RGCRGGTGATATCCCATTGTCCAT
GII.2SaV-VP1-GII.2-RGCGGGYGAAATTCCATTGTCCAT
GII.3SaV-VP1-GII.3-RGCAGGTGATATGCCRTTRTCCAT
GII.4SaV-VP1-GII.4-RGCRGGDGAKAYRCCRTTRTCCAT
GII.5SaV-VP1-GII.5-RGCRGGTGATATGCCRTTGTCCAT
GII.xSaV-VP1-GII.x-RGCDGGNGANAYNCCRTTRTCCAT
GIV.1SaV-VP1-GIV.1-RGCTGGGYGARARCCCRTTCTCCAT
GV.1SaV-VP1-GV.1-RGANGGTGARCCTCCRTTCTCCAT
Table
Table 2. Sapovirus RNA positivity in stool samples.
Table 2. Sapovirus RNA positivity in stool samples.
Cohort 0 to ≤5 Months6 Months to
≤2 Years		3 to ≤4 Years5 to 97 Years
Retrospective 2008−2009n, PR 1 95% CI4/123, 3.3% (1.3−8.1%)24/187, 12.8% (8.8−18.4%)2/32, 6.3% (1.7−20.2%)n.a.
Prospective 2010−2018n, PR 1 95% CI3/584, 0.5% (0.2−1.5%)77/1049, 7.3% (5.9−9.1%)9/249, 3.6% (1.9−6.7%)23/3673, 0.6% (0.4−0.9%)
1 PR, positivity rate.

Share and Cite

MDPI and ACS Style

Mann, P.; Pietsch, C.; Liebert, U.G. Genetic Diversity of Sapoviruses among Inpatients in Germany, 2008−2018. Viruses 2019, 11, 726. https://doi.org/10.3390/v11080726

AMA Style

Mann P, Pietsch C, Liebert UG. Genetic Diversity of Sapoviruses among Inpatients in Germany, 2008−2018. Viruses. 2019; 11(8):726. https://doi.org/10.3390/v11080726

Chicago/Turabian Style

Mann, Pia, Corinna Pietsch, and Uwe G. Liebert. 2019. "Genetic Diversity of Sapoviruses among Inpatients in Germany, 2008−2018" Viruses 11, no. 8: 726. https://doi.org/10.3390/v11080726

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop